122P Risk stratification in soft tissue sarcoma: A single-center experience using Sarculator
Soft tissue sarcomas (STS) are rare, heterogeneous malignancies requiring prognostic tools to guide treatment. Sarculator is a validated nomogram for predicting overall survival (OS) and recurrence risk in resected STS. However, data validating its performance outside its initial cohorts are limited. This study evaluates Sarculator’s predictive performance and utility for risk stratification in patients treated with neoadjuvant or adjuvant ifosfamide-epirubicin chemotherapy (CT).
Authors
- Elena Soria (ORCID: https://orcid.org/0000-0002-0913-6874)
- E. Gómez Roch
- Juan Miguel Gallego (ORCID: https://orcid.org/0000-0002-8997-1107)
- Roberto Díaz Beveridge
- P. Capdevila Gaudens
- C. Carrasco Picazo
- D. Vidal Jiménez
- C. Escrivá Aranda
- A. Ortiz Gracia
Publication Details
- Journal
- ESMO Open
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1016/j.esmoop.2025.104435
- Citations
- 1
- Primary Topic
- Sarcoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52